Th1/2 Immune Response Signature Predicts Outcome after Dose-Dense Immunochemotherapy in Patients with High Risk Diffuse Large B-Cell Lymphoma - Results from Nordic Lymphoma Group Trials

Matias Autio, Suvi-Katri Leivonen, Judit Meszaros Jorgensen, Marja-Liisa Karjalainen-Lindsberg, Klaus Beiske, Harald Holte, Sirpa Leppä

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Original languageEnglish
Article number4008
JournalBlood
Volume130
Number of pages2
ISSN0006-4971
Publication statusPublished - 7 Dec 2017
MoE publication typeNot Eligible
Event59th Annual Meeting of the American-Society-of-Hematology (ASH) - Atlanta, Gabon
Duration: 9 Dec 201712 Dec 2017

Cite this

@article{c4419e0edfa74b59bc54fff5d7309ede,
title = "Th1/2 Immune Response Signature Predicts Outcome after Dose-Dense Immunochemotherapy in Patients with High Risk Diffuse Large B-Cell Lymphoma - Results from Nordic Lymphoma Group Trials",
author = "Matias Autio and Suvi-Katri Leivonen and Jorgensen, {Judit Meszaros} and Marja-Liisa Karjalainen-Lindsberg and Klaus Beiske and Harald Holte and Sirpa Lepp{\"a}",
year = "2017",
month = "12",
day = "7",
language = "English",
volume = "130",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",

}

Th1/2 Immune Response Signature Predicts Outcome after Dose-Dense Immunochemotherapy in Patients with High Risk Diffuse Large B-Cell Lymphoma - Results from Nordic Lymphoma Group Trials. / Autio, Matias; Leivonen, Suvi-Katri; Jorgensen, Judit Meszaros; Karjalainen-Lindsberg, Marja-Liisa; Beiske, Klaus; Holte, Harald; Leppä, Sirpa.

In: Blood, Vol. 130, 4008, 07.12.2017.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

TY - JOUR

T1 - Th1/2 Immune Response Signature Predicts Outcome after Dose-Dense Immunochemotherapy in Patients with High Risk Diffuse Large B-Cell Lymphoma - Results from Nordic Lymphoma Group Trials

AU - Autio, Matias

AU - Leivonen, Suvi-Katri

AU - Jorgensen, Judit Meszaros

AU - Karjalainen-Lindsberg, Marja-Liisa

AU - Beiske, Klaus

AU - Holte, Harald

AU - Leppä, Sirpa

PY - 2017/12/7

Y1 - 2017/12/7

M3 - Meeting Abstract

VL - 130

JO - Blood

JF - Blood

SN - 0006-4971

M1 - 4008

ER -